Evidence map›Paper›PMID 28877663›Full record

ArticleBMC bioinformatics2017

High-throughput PCR assay design for targeted resequencing using primerXL.

Steve Lefever, Filip Pattyn, Bram De Wilde, Frauke Coppieters, Sarah De Keulenaer, Jan Hellemans, Jo Vandesompele

Abstract read
In one paragraph

Article in BMC bioinformatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. High rate of detected variants in maleHuman reproduction open · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Targeted resequencing and variant validation using pxlence PCR assays.Biomolecular detection and quantification · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Steve LefeverCenter for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium. Steve.Lefever@UGent.be.ORCID http://orcid.org/0000-0002-6936-8239
Filip PattynCenter for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Bram De WildeCenter for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Frauke CoppietersCenter for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Sarah De KeulenaerCenter for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Jan HellemansCenter for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Jo VandesompeleCenter for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the sequencing landscape is rapidly evolving and sequencing costs are continuously decreasing, whole genome sequencing is still too expensive for use on a routine basis. Targeted resequencing of only the regions of interest decreases both costs and the complexity of the downstream data-analysis. Various target enrichment strategies are available, but none of them obtain the degree of coverage uniformity, flexibility and specificity of PCR-based enrichment. On the other hand, the biggest limitation of target enrichment by PCR is the need to design large numbers of partially overlapping assays to cover the target.

resultsTo overcome the aforementioned hurdles, we have developed primerXL, a state-of-the-art PCR primer design pipeline for targeted resequencing. It uses an optimized design criteria relaxation cascade and a thorough downstream in silico evaluation process to generate high quality singleplex PCR assays, reducing the need for amplicon normalization, and outperforming other target enrichment strategies and similar primer design tools when considering assay quality, coverage uniformity and target coverage. Results of four different sequencing projects with 2348 amplicons in total covering 470 kb are presented. PrimerXL can be accessed at www.primerxl.org .

conclusionPrimerXL is an state-of-the-art, easy to use primer design webtool capable of generating high-quality targeted resequencing assays. The workflow is fully customizable to suit every researchers' needs, while an innovative relaxation cascade ensures maximal target coverage.

Indexed as

User-Computer InterfaceAnimalsDNA PrimersHigh-Throughput Nucleotide SequencingHumansPlantsPolymerase Chain ReactionPolymorphism, Single NucleotideSequence Analysis, DNADNA PrimersPCR assayPrimer designSanger sequencingTargeted resequencingVariant confirmation next generation sequencing

Identifiers

PMID28877663
PMCPMC5588703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.